These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24086164)

  • 1. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.
    Jiang W; Maniv I; Arain F; Wang Y; Levin BR; Marraffini LA
    PLoS Genet; 2013; 9(9):e1003844. PubMed ID: 24086164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci.
    Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA
    Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
    Goldberg GW; Jiang W; Bikard D; Marraffini LA
    Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.
    Watson BNJ; Staals RHJ; Fineran PC
    mBio; 2018 Feb; 9(1):. PubMed ID: 29440578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.
    Hatoum-Aslan A; Maniv I; Samai P; Marraffini LA
    J Bacteriol; 2014 Jan; 196(2):310-7. PubMed ID: 24187086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.
    Westra ER; Levin BR
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):27777-27785. PubMed ID: 33122438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditions for the spread of CRISPR-Cas immune systems into bacterial populations.
    Elliott JFK; McLeod DV; Taylor TB; Westra ER; Gandon S; Watson BNJ
    ISME J; 2024 Jan; 18(1):. PubMed ID: 38896653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity.
    Rostøl JT; Marraffini LA
    Nat Microbiol; 2019 Apr; 4(4):656-662. PubMed ID: 30692669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
    Levin BR; Moineau S; Bushman M; Barrangou R
    PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-chaotic oscillations in CRISPR-virus coevolution predicted by bifurcation analysis.
    Berezovskaya FS; Wolf YI; Koonin EV; Karev GP
    Biol Direct; 2014 Jul; 9():13. PubMed ID: 24986220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CRISPR/cas system in the development of bacteriophage resistance.
    Szczepankowska A
    Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape.
    Pyenson NC; Gayvert K; Varble A; Elemento O; Marraffini LA
    Cell Host Microbe; 2017 Sep; 22(3):343-353.e3. PubMed ID: 28826839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for the Analysis and Characterization of Defense Mechanisms Against Horizontal Gene Transfer: CRISPR Systems.
    Calvo-Villamañán A; Bernheim A; Bikard D
    Methods Mol Biol; 2020; 2075():235-249. PubMed ID: 31584167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.
    Smith LM; Jackson SA; Malone LM; Ussher JE; Gardner PP; Fineran PC
    Nat Microbiol; 2021 Feb; 6(2):162-172. PubMed ID: 33398095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of CRISPR-mediated microbial immunity.
    Gasiunas G; Sinkunas T; Siksnys V
    Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
    Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR decoys: competitive inhibitors of CRISPR immunity.
    Maniv I; Hatoum-Aslan A; Marraffini LA
    RNA Biol; 2013 May; 10(5):694-9. PubMed ID: 23584158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.